Stock listing

Euronext:MAAT MaaT Pharma Action

Home listing (Euronext) of MaaT Pharma

Follow MaaT Pharma into a list and get an email when it puts out news.

Share price · EURONEXT:MAAT

€1.02 EUR -0.05 (-4.9%)

Close on Oct 30, 2026

Past year -75.7% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
€1.02 – €1.12 EUROct 30, 2026
Volume
89,787 sharesOct 30, 2026
Market cap
€19.16M EURAt the close on Oct 30, 2026 · price × 18.82M shares outstanding
52-week range
€0.903 – €8.62 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
€149,448 EURMedian day 38,283 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
MaaT Pharma logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:MAAT · Home€1.018 EUR-0.052 (-4.9%)89,787€1.092€1.122€1.016€1.07Close on Oct 30, 2026
Frankfurt:4RD€0.988 EUR-0.024 (-2.4%)—€1.028€1.046€0.988€1.012Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · EURONEXT:MAAT · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.018-0.052-4.9%€1.092€1.122€1.01689,787
€1.07+0.028+2.7%€1.042€1.09€1.0371,712
€1.042-0.002-0.2%€1.042€1.052€1.01884,368
€1.044-0.018-1.7%€1.07€1.07€1.03842,221
€1.062-0.006-0.6%€1.08€1.09€1.03831,788
€1.068+0.006+0.6%€1.12€1.12€1.05837,054
€1.062-0.034-3.1%€1.14€1.14€1.03855,514
€1.096+0.076+7.5%€1.05€1.19€1.014198,814
€1.02+0.02+2.0%€1.25€1.30€1.02490,141
€1.00+0.01+1.0%€0.99€1.026€0.98257,407
€0.99+0.016+1.6%€0.97€0.99€0.96122,578
€0.974+0.033+3.5%€0.951€0.974€0.9323,905
€0.941+0.028+3.1%€0.94€0.951€0.90830,902
€0.913+0.005+0.6%€0.93€0.93€0.91211,589
€0.908-0.014-1.5%€0.906€0.92€0.90339,248
€0.922-0.008-0.9%€0.95€0.95€0.90422,293
€0.93-0.053-5.4%€0.96€0.979€0.9319,570
€0.983-0.007-0.7%€0.99€0.991€0.9561,084
€0.99+0.051+5.4%€0.982€1.01€0.92569,515
€0.939-0.071-7.0%€1.01€1.014€0.916195,649
€1.01-0.02-1.9%€1.032€1.08€1.00154,897
€1.03-0.054-5.0%€1.09€1.186€1.01112,846
€1.084-0.046-4.1%€1.11€1.13€1.08292,618
€1.13-0.01-0.9%€1.25€1.25€1.1373,643
€1.14+0.006+0.5%€1.27€1.28€1.14156,328
€1.134-0.128-10.1%€1.296€1.296€1.134137,369
€1.262-0.096-7.1%€1.39€1.39€1.252120,579
€1.358-0.072-5.0%€1.388€1.418€1.312130,781
€1.43+0.13+10.0%€1.368€1.59€1.33353,541
€1.30-0.33-20.2%€1.63€1.66€1.30315,707
€1.63-0.37-18.5%€2.02€2.22€1.63417,364
€2.00+0.56+38.9%€1.44€2.00€1.44422,021
€1.44+0.36+33.3%€1.108€1.47€1.108410,459
€1.08-1.435-57.1%€1.06€1.16€1.00444,282
€2.515-0.22-8.0%€2.68€2.68€2.5179,774
€2.735-0.055-2.0%€2.78€2.88€2.7033,087
€2.79+0.135+5.1%€2.66€2.835€2.6638,283
€2.655-0.145-5.2%€2.75€2.785€2.6534,428
€2.80-0.08-2.8%€2.89€2.895€2.7835,012
€2.88-0.06-2.0%€2.96€2.96€2.8028,531
€2.94+0.005+0.2%€3.045€3.045€2.9425,902
€2.935-0.025-0.8%€2.96€2.965€2.9213,621
€2.96-0.045-1.5%€2.97€3.00€2.967,517
€3.005+0.045+1.5%€3.00€3.075€2.96527,930
€2.96-0.065-2.1%€3.03€3.03€2.9224,554
€3.025+0.005+0.2%€3.03€3.075€2.9628,125
€3.02+0.03+1.0%€3.00€3.07€2.9422,385
€2.99-0.05-1.6%€3.05€3.06€2.9823,536
€3.04-0.005-0.2%€3.06€3.09€2.9832,349
€3.045-0.145-4.5%€3.28€3.28€2.95580,235
€3.19+0.07+2.2%€3.12€3.40€3.05131,751
€3.12-0.03-1.0%€3.26€3.38€3.06577,249
€3.15+0.22+7.5%€2.90€3.38€2.90164,209
€2.93-0.045-1.5%€2.98€2.98€2.938,569
€2.975+0.085+2.9%€2.94€2.975€2.8919,523
€2.89-0.06-2.0%€2.94€3.03€2.8833,670
€2.95+0.05+1.7%€2.86€3.00€2.8639,076
€2.90+0.04+1.4%€2.89€2.95€2.8035,847
€2.860.000.0%€2.84€2.915€2.80518,993
€2.86-0.03-1.0%€2.89€2.89€2.7718,858
€2.89+0.06+2.1%€2.80€2.92€2.8041,163
€2.83+0.02+0.7%€2.80€2.83€2.76531,464
€2.81+0.02+0.7%€2.76€2.81€2.72524,378
€2.790.000.0%€2.77€2.82€2.76510,941
€2.79+0.01+0.4%€2.82€2.85€2.7820,686
€2.78-0.015-0.5%€2.80€2.86€2.77519,989
€2.795+0.005+0.2%€2.80€2.86€2.76523,151
Ticker
Euronext:MAAT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

MaaT Pharma Receives FDA Feedback Following Pre-IND Meeting Supporting Continued Development of MaaT034 in Solid Tumors

Oct 19, 2026

Closed €1.02 (+2.0%) on Oct 20, 2026

MaaT Pharma Publishes its Half-Year 2026 Results and Provides a Business Update

Sep 29, 2026

Closed €1.08 (-4.1%) on Sep 30, 2026

MaaT Pharma publie ses résultats semestriels 2026 et fait le point sur ses activités

Sep 29, 2026

Closed €1.13 (-0.9%) on Sep 29, 2026

MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors

Sep 21, 2026

Closed €1.43 (+10.0%) on Sep 22, 2026

MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination

Sep 18, 2026

Closed €1.63 (-18.5%) on Sep 18, 2026

MaaT Pharma Receives Negative CHMP Trend Vote for MaaT013 (Xervyteg®) Following Re-Examination for its Conditional Marketing Authorization Application in Europe

Sep 15, 2026

Closed €1.08 (-57.1%) on Sep 15, 2026

MaaT Pharma Presents the Results of its Annual General Meeting and Provides a Statement on its Half-Year Liquidity Contract

Jul 6, 2026

Closed €2.70 (-1.5%) on Jul 7, 2026

MaaT Pharma Announces Plan to Request Re-Examination Following Negative CHMP Opinion for MaaT013 for the treatment of acute Graft-versus-Host Disease

Jun 29, 2026

Closed €2.45 (-3.2%) on Jun 29, 2026

MaaT Pharma Provides Business Update and Reports Financial Results for the First Quarter 2026

May 26, 2026

Closed €2.81 (-4.6%) on May 27, 2026

MaaT Pharma Announces Provides an Update on the Application for Marketing Authorization of MaaT013 in the treatment of acute Graft-versus-Host Disease

May 21, 2026

Closed €3.26 (+9.2%) on May 22, 2026

All MaaT Pharma news

Decks

MaaT Pharma on 6ix

Sector
Health care
Industry
Biotechnology
News releases
25 in the last 12 months · 38 in all · newest Oct 19, 2026 · oldest 2025
Decks
21 decks · latest October 2026

Where MaaT Pharma is listed

ListingExchangeCountryCurrency
Euronext:MAAT · Home listing · This pageEuronextFranceEUR
gettex:4RDgettexGermanyEUR
LS Exchange:A3C7A5LS ExchangeGermanyEUR
Lang & Schwarz:A3C7A5Lang & SchwarzGermanyEUR
Frankfurt:4RDFrankfurtGermanyEUR
OTC:MATPFOTCUnited StatesUSD
Hamburg:4RDHamburgGermanyEUR
Munich:4RDMunichGermanyEUR
Stuttgart:4RDStuttgartGermanyEUR
Dusseldorf:4RDDusseldorfGermanyEUR

Log in to ask 6ix AI your own questions about MaaT Pharma.